Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test

Pharmacol Res. 1995 Jul-Aug;32(1-2):49-55. doi: 10.1016/s1043-6618(95)80008-5.

Abstract

We investigated the effect of gallopamil administration during a cold pressor test (CPT) in 18 patients suffering from chronic angina (CA) and in 21 healthy subjects. CA patients showed increased basal levels of beta-thromboglobulin and thromboxane B2 compared to control patients and normal plasma levels of catecholamines. CPT caused plasma catecholamines, beta-thromboglobulin and TxB2 levels to rise. This rise was greater in CA patients than in control patients. Administration of gallopamil (50 mg kg-1 three times a day for 30 days) reduced plasma levels of catecholamines, beta-thromboglobulin and TxB2 blood concentrations either under basal conditions or after CPT. Our data suggest that gallopamil is able to modulate the response induced by adrenergic stress.

MeSH terms

  • Adult
  • Aged
  • Angina Pectoris / blood
  • Calcium Channel Blockers / pharmacology*
  • Cold Temperature
  • Coronary Disease / drug therapy
  • Epinephrine / blood*
  • Female
  • Gallopamil / pharmacology*
  • Humans
  • Male
  • Middle Aged
  • Norepinephrine / blood*
  • Thromboxane B2 / blood*
  • beta-Thromboglobulin / metabolism*

Substances

  • Calcium Channel Blockers
  • beta-Thromboglobulin
  • Gallopamil
  • Thromboxane B2
  • Norepinephrine
  • Epinephrine